Literature DB >> 15976491

TLR signalling and the function of dendritic cells.

Hiroaki Hemmi1, Shizuo Akira.   

Abstract

The recognition of microbes by innate immune cells initiates activation of the whole immune system. Toll-like receptors (TLRs) are known to recognize various components of invading pathogens. At present, the natural ligands for almost all TLR members have been identified. TLRs are expressed on many types of cells including macrophages and dendritic cells (DCs). The recognition of invading microbes by TLRs on DCs induces proinflammatory cytokine production and enhanced antigen presentation to naive T cells, and finally activates antigen-specific adaptive immune responses. The sequential activation of innate and subsequent adaptive immunity are crucial steps to eradicate invading pathogens. Recently, the TLR signalling pathway has been intensively investigated. Accumulating evidence indicates that, at least, four adaptor molecules are involved in TLR signalling and provide their signalling specificities. Distinct TLR ligands provide distinct activation status and cytokine production patterns for antigen presenting cells, resulting in the induction of differential immune responses. Thus, TLRs are critical molecules to induce not only inflammatory responses but also fine-tuned adaptive immune responses depending on invading pathogens.

Mesh:

Substances:

Year:  2005        PMID: 15976491     DOI: 10.1159/000086657

Source DB:  PubMed          Journal:  Chem Immunol Allergy        ISSN: 0079-6034


  83 in total

1.  Dendritic cell activation prevents MHC class II ubiquitination and promotes MHC class II survival regardless of the activation stimulus.

Authors:  Even Walseng; Kazuyuki Furuta; Romina S Goldszmid; Karis A Weih; Alan Sher; Paul A Roche
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

2.  TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines.

Authors:  Elena Y Enioutina; Diana Bareyan; Raymond A Daynes
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

3.  Schistosoma mansoni egg antigen-mediated modulation of Toll-like receptor (TLR)-induced activation occurs independently of TLR2, TLR4, and MyD88.

Authors:  Colleen M Kane; Euihye Jung; Edward J Pearce
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

Review 4.  Induction and maintenance of protective CD8+ T cells against malaria liver stages: implications for vaccine development.

Authors:  Sze-Wah Tse; Andrea J Radtke; Fidel Zavala
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

Review 5.  Toll-like receptor signaling in neural plasticity and disease.

Authors:  Eitan Okun; Kathleen J Griffioen; Mark P Mattson
Journal:  Trends Neurosci       Date:  2011-03-16       Impact factor: 13.837

Review 6.  Recent Advances in Good Manufacturing Practice-Grade Generation of Dendritic Cells.

Authors:  Sarah Cunningham; Holger Hackstein
Journal:  Transfus Med Hemother       Date:  2020-10-28       Impact factor: 3.747

Review 7.  Dendritic cells: The warriors upfront-turned defunct in chronic hepatitis C infection.

Authors:  Meenakshi Sachdeva; Yogesh K Chawla; Sunil K Arora
Journal:  World J Hepatol       Date:  2015-09-08

8.  UNC93B1 and nucleic acid-sensing Toll-like receptors mediate host resistance to infection with Leishmania major.

Authors:  Bruno Luiz Fonseca Schamber-Reis; Patricia M Petritus; Braulia C Caetano; Espiridion R Martinez; Kendi Okuda; Douglas Golenbock; Phillip Scott; Ricardo T Gazzinelli
Journal:  J Biol Chem       Date:  2013-01-16       Impact factor: 5.157

9.  Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production.

Authors:  Mikyoung Chang; Wei Jin; Shao-Cong Sun
Journal:  Nat Immunol       Date:  2009-09-06       Impact factor: 25.606

10.  Functional impairment of human myeloid dendritic cells during Schistosoma haematobium infection.

Authors:  Bart Everts; Ayola A Adegnika; Yvonne C M Kruize; Hermelijn H Smits; Peter G Kremsner; Maria Yazdanbakhsh
Journal:  PLoS Negl Trop Dis       Date:  2010-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.